Ascending Single-Dose Study to Evaluate VIA-3196 in Healthy Subjects
Clinical trial NCT01367873 · COMPLETED
Trial details
- NCT number
- NCT01367873
- Sponsor
- Madrigal Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2011-10-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.